Shanghai Shen Lian Biomedical Corporation (688098.SH): Swine Pseudorabies Live Vaccine (Strain JS-A1) Approved as New Veterinary Drug.

Shanghai Shen Lian Biomedical Corporation (688098.SH) announced that, according to the "Regulations on the Administration of Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs", the company's swine pseudorabies live vaccine (strain JS-A1) has been approved as a new veterinary drug by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. This vaccine is used to prevent swine pseudorabies, with immunity developing 21 days after vaccination and lasting for 6 months. The swine pseudorabies live vaccine (strain JS-A1) has been approved as a new veterinary drug, which will further enrich the company's range of animal vaccine products. The company's non-foot-and-mouth disease vaccine series will also be enriched, facilitating the company in providing comprehensive disease prevention and control solutions for users, especially large-scale pig farms, to enhance the company's core competitiveness.